Search Results - Adam Samuta
- Showing 1 - 3 results of 3
-
1
Assessment of Reader Technologies for Over-the-Counter Diagnostic Testing by Mia Cirrincione, Maren Downing, Kevin Leite, Samuel Dolphin, Adam Samuta, Mack Schermer, Kimberly Noble, Brian Walsh
Published 2024-01-01<bold>Background:</bold> Over-the-counter (OTC) diagnostic testing is on the rise with many in vitro diagnostic tests being lateral flow assays (LFAs). A growing number of these are adopting reader technologies, which provides an alternative to visual readouts for results interpretation,...
Get full text
Article -
2
RADx Variant Task Force Program for Assessing the Impact of Variants on SARS-CoV-2 Molecular and Antigen Tests by Richard Creager, John Blackwood, Thomas Pribyl, Leda Bassit, Anuradha Rao, Morgan Greenleaf, Filipp Frank, Wilbur Lam, Eric Ortlund, Raymond Schinazi, Alexander Greninger, Mia Cirrincione, Dale Gort, Emily Kennedy, Adam Samuta, Megan Shaw, Brian Walsh, Eric Lai
Published 2021-01-01<italic>Goal:</italic> Monitoring the genetic diversity and emerging mutations of SARS-CoV-2 is crucial for understanding the evolution of the virus and assuring the performance of diagnostic tests, vaccines, and therapies against COVID-19. SARS-CoV-2 is still adapting to humans and, as...
Get full text
Article -
3
The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech by Matthew Robinson, Charlotte Gaydos, Barbara Van Der Pol, Sally McFall, Yu-Hsiang Hsieh, William Clarke, Robert L. Murphy, Lea E. Widdice, Lisa R. Hirschhorn, Richard Rothman, Chad Achenbach, Claudia Hawkins, Adam Samuta, Laura Gibson, David McManus, Yukari C. Manabe
Published 2021-01-01The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect�...
Get full text
Article